Bone Cancer

• DOI: 10.6004/jnccn.2013.0088
• Publication Date: 2017-04-14T12:03:30Z
• Authors: J. Sybil Biermann; Douglas R. Adkins; Mark Agulnik; Robert S. Benjamin; Brian Brigman; James E. Butrynski; David Cheong; Warren Chow; William T. Curry; Deborah A. Frassica; Frank J. Frassica; Kenneth R. Hande; Francis J. Hornicek; Robin L. Jones; Joel Mayerson; Sean V. McGarry; Brian McGrath; Carol D. Morris; Richard J. O'Donnell; R. Lor Randall; Victor M. Santana; Robert L. Satcher; Herrick J. Siegel; Margaret von Mehren; Mary Anne Bergman; Hema Sundar
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Humans; Bone Neoplasms; Neoplasm Staging; 3. Good health

Primary bone cancers are extremely rare neoplasms, accounting for fewer than 0.2% of all cancers. The evaluation and treatment of patients with bone cancers requires a multidisciplinary team of physicians, including musculoskeletal, medical, and radiation oncologists, and surgeons and radiologists with demonstrated expertise in the management of these tumors. Long-term surveillance and follow-up are necessary for the management of treatment late effects related to surgery, radiation therapy, and chemotherapy. These guidelines discuss the management of chordoma, giant cell tumor of the bone, and osteosarcoma.